Evidence map›Paper›PMID 31596884›Full record

ArticlePloS one2019

The impact of PEPFAR transition on HIV service delivery at health facilities in Uganda.

Jess Alan Wilhelm, Mary Qiu, Ligia Paina, Elizabeth Colantuoni, Moses Mukuru, Freddie Ssengooba, Sara Bennett

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jess Alan WilhelmJohns Hopkins University, Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.ORCID 0000-0001-9299-7984
Mary QiuJohns Hopkins University, Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Ligia PainaJohns Hopkins University, Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Elizabeth ColantuoniJohns Hopkins University, Bloomberg School of Public Health, Department of Biostatistics, Baltimore, Maryland, United States of America.
Moses MukuruMakerere University, School of Public Health, Department of Health Policy, Planning & Management, Kampala, Uganda.
Freddie SsengoobaMakerere University, School of Public Health, Department of Health Policy, Planning & Management, Kampala, Uganda.
Sara BennettJohns Hopkins University, Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.

Funding

PEPFAR
6 · The paper itself

Abstract

backgroundSince 2004, the President's Emergency Plan for AIDS Relief (PEPFAR) has played a large role in Uganda's HIV/AIDS response. To better target resources to high burden regions and facilities, PEPFAR planned to withdraw from 29% of previously-supported health facilities in Uganda between 2015 and 2017.

methodsWe conducted a cross-sectional survey of 226 PEPFAR-supported health facilities in Uganda in mid-2017. The survey gathered information on availability, perceived quality, and access to HIV services before and after transition. We compare responses for facilities transitioned to those maintained on PEPFAR, accounting for survey design. We also extracted data from DHIS2 for the period October 2013-December 2017 on the number of HIV tests and counseling (HTC), number of patients on antiretroviral therapy (Current on ART), and retention on first-line ART (Retention) at 12 months. Using mixed effect models, we compare trends in service volume around the transition period.

resultsThere were 206 facilities that reported transition and 20 that reported maintenance on PEPFAR. Some facilities reporting transition may have been in a gap between implementing partners. The median transition date was September 2016, nine months prior to the survey. Transition facilities were more likely to discontinue HIV outreach following transition (51.6% vs. 1.4%, p<0.001) and to report declines in HIV care access (43.5% vs. 3.1%, p<0.001) and quality (35.6% vs. 0%, p<0.001). However, transition facilities did not differ in their trends in HIV service volume relative to maintenance facilities.

conclusionsTransition from PEPFAR resulted in facilities reporting worsening patient access and service quality for HIV care, but there is insufficient evidence to suggest negative impacts on volume of HIV services. Facility respondents' perceptions about access and quality may be overly pessimistic, or they may signal forthcoming impacts. Unrelated to transition, declining retention on ART in Uganda is a cause for concern.

Indexed as

Government ProgramsAcquired Immunodeficiency SyndromeDelivery of Health CareHealth Plan ImplementationProgram EvaluationUganda

Identifiers

PMID31596884
PMCPMC6785126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.